Long-acting injectable cabotegravir highly effective at preventing HIV infection
The HIV Prevention Trials Network (HPTN) announced today results from HPTN 083, a global randomized, controlled, double-blind study that compared the safety and efficacy of long-acting injectable cabotegravir (CAB LA) to ...
May 19, 2020
0
8